Clinical Drug Investigation

SJR Rank #6,638H-index: 75SJR: 0.823Best quartile: Q2APC: US$4,190
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Blood Pressure and Hypertension StudiesAntibiotics Pharmacokinetics and EfficacyDiabetes Treatment and ManagementInflammatory mediators and NSAID effectsAsthma and respiratory diseasesPain Management and Opioid UsePharmacogenetics and Drug MetabolismPneumonia and Respiratory InfectionsAnesthesia and Pain ManagementPharmacological Effects and Toxicity Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs075150225300

Documents per Year

202220250306090120

Detailed Information

ISSN

1179-1918, 1173-2563

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.81

References per Document

43.99

Coverage

1995-2026

Scope

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes: -Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs. -Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice. -Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed. -Studies focusing on the application of drug delivery technology in healthcare. -Short communications and case study reports that meet the above criteria will also be considered. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.

Metrics from SCImago Journal Rank 2025. View on SCImago